4.7 Article

Three-dimensional human neural culture on a chip recapitulating neuroinflammation and neurodegeneration

Journal

NATURE PROTOCOLS
Volume 18, Issue 9, Pages 2838-2867

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41596-023-00861-4

Keywords

-

Ask authors/readers for more resources

This article describes a protocol for fabricating a microfluidic device and using it in three-dimensional human neural cultures to study neuron-glia interactions in neuroinflammation and neurodegeneration. The device can replicate pathological features of major neurological disorders and reveal the mechanisms of neuro-glia interactions. The protocol requires training in basic molecular biology techniques.
Protocol for the fabrication of a microfluidic device and its implementation in three-dimensional human neural cultures, allowing the study of neuron-glia interactions in neuroinflammation and neurodegeneration. Neuroinflammation has either beneficial or detrimental effects, depending on risk factors and neuron-glia interactions in neurological disorders. However, studying neuroinflammation has been challenging due to the complexity of cell-cell interactions and lack of physio-pathologically relevant neuroinflammatory models. Here, we describe our three-dimensional microfluidic multicellular human neural culture model, referred to as a 'brain-on-a-chip' (BoC). This elucidates neuron-glia interactions in a controlled manner and recapitulates pathological signatures of the major neurological disorders: dementia, brain tumor and brain edema. This platform includes a chemotaxis module offering a week-long, stable chemo-gradient compared with the few hours in other chemotaxis models. Additionally, compared with conventional brain models cultured with mixed phenotypes of microglia, our BoC can separate the disease-associated microglia out of heterogeneous population and allow selective neuro-glial engagement in three dimensions. This provides benefits of interpreting the neuro-glia interactions while revealing that the prominent activation of innate immune cells is the risk factor leading to synaptic impairment and neuronal loss, validated in our BoC models of disorders. This protocol describes how to fabricate and implement our human BoC, manipulate in real time and perform end-point analyses. It takes 2 d to set up the device and cell preparations, 1-9 weeks to develop brain models under disease conditions and 2-3 d to carry out analyses. This protocol requires at least 1 month training for researchers with basic molecular biology techniques. Taken together, our human BoCs serve as reliable and valuable platforms to investigate pathological mechanisms involving neuroinflammation and to assess therapeutic strategies modulating neuroinflammation in neurological disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available